Guggenheim initiates Avalyn Pharma stock with buy rating on fibrosis drugs

Guggenheim initiates Avalyn Pharma stock with buy rating on fibrosis drugs

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.